多替阿巴拉米片治什么？

It is an innovative drug for AIDS treatment by ViiV Healthcare, a joint venture company of GlaxoSmithKline (GSK). It is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.  

Thirty years ago, AIDS was almost equivalent to a terminal illness. Through the joint efforts of doctors and scientists, significant progress has been made in AIDS treatment. Currently, AIDS is becoming a controllable chronic disease. As of June 30, 2016, there were more than 620,000 living HIV/AIDS patients reported across the country, more than 190,000 reported deaths, and more than 420,000 patients currently receiving antiretroviral treatment. 

The specifications of Dolutegra Abalami Tablets are 50mg/600mg/300mgx30 tablets. It is suitable for the treatment of human immunodeficiency virus infection. It can be used by adults and adolescents over 12 years old, but please note that the patient's weight must be at least 40kg. HIV is an extremely scary virus. After being infected with AIDS, many people worry about whether they will die soon. The fear that AIDS brings to patients is terrifying. Dolutegravir tablets are compound medicines. Each tablet contains 50 mg of dolutegravir sodium, 600 mg of abacavir sulfate, and 300 mg of lamivudine. It is suitable for treating HIV adults and patients over 12 years old. Among them, the dolutegravir component can block the strand transfer of DNA integration through binding to the integrase active site, which is one of the key steps for HIV replication, thereby inhibiting HIV integrase in the body. 

Once infected with AIDS, it will lead to a rapid decline in immunity. When immunity declines, it is easy to get sick and other symptoms will appear. When the HIV virus enters the human body, it will not make the human body feel abnormal very quickly, so the disease needs to be treated. There are many hazards. Due to the decline of the body's resistance, various infections will occur, such as herpes zoster, oral mold infection, tuberculosis, enteritis, pneumonia, encephalitis caused by special pathogenic microorganisms, severe infections caused by Candida, Pneumocystis jiroveci and other pathogens. In the later stage, malignant tumors often occur, and long-term consumption occurs, leading to systemic failure and death. The advent of AIDS has helped patients alleviate their pain to a certain extent, delayed the progression of the disease, and brought hope to AIDS patients.